Dobek Maria 4
4 · Janux Therapeutics, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Dobek Maria
Vice President, Accounting
Transactions
- Award
Common Stock
2025-01-02+14,000→ 14,001 total - Award
Stock option (right to buy)
2025-01-02+31,500→ 31,500 totalExercise: $53.24Exp: 2035-01-01→ Common Stock (31,500 underlying)
Footnotes (3)
- [F1]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2026.
- [F2]Includes 1 share acquired under the Issuer's 2021 Employee Stock Purchase Plan (the "Plan") on November 15, 2024.
- [F3]25% of the shares subject to the option vest on January 1, 2026 and the balance will vest in equal monthly installments thereafter over a three year period.